Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease

Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30–50% of patients, and represents a leading cause of death of DM. Serotonin or 5-hydroxytryptamine (5-HT) is a multifunctional bioamine that has crucial roles in many physiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu, Huang, Hui, Xu, Zheng, Duan, Jun-kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591914/
https://www.ncbi.nlm.nih.gov/pubmed/28929122
http://dx.doi.org/10.1155/2017/7680576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591914/
https://www.ncbi.nlm.nih.gov/pubmed/28929122
http://dx.doi.org/10.1155/2017/7680576

Ejemplares similares